Ex Parte Seul et al - Page 7

                Appeal 2007-2448                                                                             
                Application 10/192,352                                                                       

                Turner (id. at 11-14).  Claims 37, 41, and 42 stand rejected under 35 U.S.C.                 
                § 103 as obvious over Kobylecki, Goldberg, and Anderson (id. at 14-16).                      
                      Claim 2 is the only independent claim, and therefore all of the claims                 
                rejected as obvious require claim 2’s step of “assembling bead arrays                        
                comprising many differently optically encoded beads having biomolecules                      
                attached thereto said biomolecules being identified by said optical                          
                encoding.”  In each of the obviousness rejections, the Examiner relies solely                
                on Kobylecki’s disclosure to meet that limitation (see Answer 7, 12, 15).  As                
                discussed above, however, we do not agree with the Examiner that                             
                Kobylecki discloses that limitation.  Moreover, the Examiner does not point                  
                to, and we do not see, where Kobylecki or any of the other references                        
                suggests performing claim 2’s “assembling” step.                                             
                      “[O]bviousness requires a suggestion of all limitations in a claim,”                   
                CFMT, Inc. v. Yieldup Intern. Corp., 349 F.3d 1333, 1342 (Fed. Cir. 2003)                    
                (citing In re Royka, 490 F.2d 981, 985 (CCPA 1974)).  Because we do not                      
                agree with the Examiner that the cited references suggest a process having                   
                claim 2’s step of “assembling bead arrays comprising many differently                        
                optically encoded beads having biomolecules attached thereto said                            
                biomolecules being identified by said optical encoding,” and because all of                  
                the claims rejected as obvious require that step, we reverse the Examiner’s                  
                obviousness rejections of claims 2, 9, 24, 26-29, 35-37, 41, and 42.                         
                                                SUMMARY                                                      
                      We reverse the Examiner’s rejection of claims 2 and 26-29 under 35                     
                U.S.C. § 102(e) as anticipated by Kobylecki.  We also reverse the                            



                                                     7                                                       

Page:  Previous  1  2  3  4  5  6  7  8  Next

Last modified: September 9, 2013